- Home
- ERJ vs EXAS Comparison
ERJ vs EXAS Comparison
Compare ERJ & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ERJ
- EXAS
- Stock Information
- Founded
- ERJ 1969
- EXAS 1995
- Country
- ERJ Brazil
- EXAS United States
- Employees
- ERJ N/A
- EXAS N/A
- Industry
- ERJ Aerospace
- EXAS Medical Specialities
- Sector
- ERJ Industrials
- EXAS Health Care
- Exchange
- ERJ Nasdaq
- EXAS Nasdaq
- Market Cap
- ERJ 9.4B
- EXAS 10.7B
- IPO Year
- ERJ 2000
- EXAS N/A
- Fundamental
- Price
- ERJ $53.81
- EXAS $51.91
- Analyst Decision
- ERJ Buy
- EXAS Strong Buy
- Analyst Count
- ERJ 6
- EXAS 20
- Target Price
- ERJ $50.40
- EXAS $70.26
- AVG Volume (30 Days)
- ERJ 1.9M
- EXAS 2.8M
- Earning Date
- ERJ 08-07-2025
- EXAS 07-30-2025
- Dividend Yield
- ERJ 0.09%
- EXAS N/A
- EPS Growth
- ERJ 70.71
- EXAS N/A
- EPS
- ERJ 0.52
- EXAS N/A
- Revenue
- ERJ $6,519,769,233.00
- EXAS $2,828,128,000.00
- Revenue This Year
- ERJ N/A
- EXAS $14.58
- Revenue Next Year
- ERJ $13.68
- EXAS $12.75
- P/E Ratio
- ERJ $102.72
- EXAS N/A
- Revenue Growth
- ERJ 39.31
- EXAS 11.57
- 52 Week Low
- ERJ $26.04
- EXAS $39.97
- 52 Week High
- ERJ $61.65
- EXAS $72.83
- Technical
- Relative Strength Index (RSI)
- ERJ 50.29
- EXAS 44.34
- Support Level
- ERJ $51.60
- EXAS $52.00
- Resistance Level
- ERJ $61.65
- EXAS $55.90
- Average True Range (ATR)
- ERJ 1.97
- EXAS 2.31
- MACD
- ERJ -0.33
- EXAS -0.04
- Stochastic Oscillator
- ERJ 27.03
- EXAS 24.90
About ERJ Embraer S.A.
Embraer SA based in Sao Paulo, Brazil, manufacturer of jets. Its focus is to achieve customer satisfaction with and services addressing the commercial airline, executive jets, and defense and security markets. It has developed a customer-centric technology-driven portfolio of commercial aviation products and services that allows it to build long-term relationships with clients in the commercial aviation, executive jets, and defense and security markets. It operates through the various segments namely Commercial Aviation, Defense and Security, Executive Aviation, Service and Support, and Other Segments. The company generates maximum revenue from the Commercial Aviation segment.
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.